TrialNaunyn-Schmiedeberg's archives of pharmacology2016

Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.

Mohd Ashif Khan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.